ACCESSION: MSBNK-SMB_Measured-HSA015P0088017
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.31, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 14
COMMENT: RAW_SPEC {'EL16_pos_1473': {'bp': 1644589.0, 'sum': 2108440.0}, 'EL09_pos_1487': {'bp': 680018.0, 'sum': 1140512.0}, 'EL12_pos_1475': {'bp': 853722.0, 'sum': 1237928.0}, 'EL08_pos_1481': {'bp': 1014326.0, 'sum': 1359835.0}, 'EL14_pos_1475': {'bp': 1059458.0, 'sum': 1441979.0}, 'EL24_pos_1469': {'bp': 743473.0, 'sum': 1145154.0}, 'EL05_pos_1475': {'bp': 1241781.0, 'sum': 1683786.0}, 'EL20_pos_1475': {'bp': 754346.0, 'sum': 1133366.0}, 'EL21_pos_1481': {'bp': 609642.0, 'sum': 1038351.0}, 'EL04_pos_1478': {'bp': 1241700.0, 'sum': 1675391.0}, 'EL06_pos_1481': {'bp': 1034964.0, 'sum': 1434420.0}, 'EL23_pos_1474': {'bp': 1399648.0, 'sum': 1836652.0}, 'EL19_pos_1490': {'bp': 873302.0, 'sum': 1313767.0}, 'EL13_pos_1472': {'bp': 1090033.0, 'sum': 1477384.0}}
COMMENT: RETENTION_TIME_STDEV 0.009
COMMENT: PRECURSOR_M/Z_RAW 88.076333
COMMENT: PRECURSOR_M/Z_STDEV 0.000031
COMMENT: PRECURSOR_IN_MS1 mz 88.075680; int 47.208; delta(ppm) 0.495802
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+H; M+ACN+H; mz 129.102254; int 8.168; cor 0.771
COMMENT: PROPOSED_ION_FORM M+H; M+2ACN+H; mz 170.128719; int 2.946; cor 0.648
COMMENT: PROPOSED_ION_FORM M+Na; M+ACN+Na; mz 129.102254; int 8.168; cor 0.771
COMMENT: PROPOSED_ION_FORM M+ACN+H; M+2ACN+H; mz 129.102254; int 8.168; cor 0.771
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.092; C4H9NO; [M+H]+; delta(ppm) -0.091882
COMMENT: PROPOSED_MF SevenGoldenRules 0.130; C2H6O; [M+ACN+H]+; delta(ppm) -0.130316
COMMENT: PROPOSED_MF MS-FINDER 3.424; C4H9NO; [M+H]+; delta(ppm) -0.094787
COMMENT: PROPOSED_MF MS-FINDER 2.329; C2H6O; [M+ACN+H]+; delta(ppm) 205653.814814
COMMENT: PROPOSED_MF SIRIUS6_Sirius 0.996; C2H6O; [M+C2H3N+H]+; delta(ppm) -0.094787
COMMENT: PROPOSED_MF SIRIUS6_Sirius 0.996; C4H9NO; [M+H]+; delta(ppm) -0.094787
COMMENT: PROPOSED_MF SIRIUS6_Sirius -4.288; H4N3; [M+C2H3N+H]+; delta(ppm) 15.149873
COMMENT: PROPOSED_MF SIRIUS6_Sirius -4.288; C2H7N4; [M+H]+; delta(ppm) 15.149873
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.995; C4H9NO; [M+H]+; delta(ppm) -0.094787
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.994; C2H6O; [M+C2H3N+H]+; delta(ppm) -0.094787
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.006; H4N3; [M+C2H3N+H]+; delta(ppm) 15.149873
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 0.005; C2H7N4; [M+H]+; delta(ppm) 15.149873
COMMENT: PROPOSED_COMPOUND SIMILARITY:GNPS 1.000; YNAVUWVOSKDBBP-UHFFFAOYSA-N; C4H9NO; MassbankEU:SM836501 MorpholineMorpholin
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.486; YNAVUWVOSKDBBP-UHFFFAOYSA-N; [M+H]+; C1COCCN1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.400; DNSISZSEWVHGLH-UHFFFAOYSA-N; [M+H]+; CCCC(N)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.400; GRWPTSXPZYCYOM-UHFFFAOYSA-N; [M+H]+; CN(C)CC=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.400; FXHOOIRPVKKKFG-UHFFFAOYSA-N; [M+H]+; CN(C)C(C)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.400; KGGVGTQEGGOZRN-UHFFFAOYSA-N; [M+H]+; CCCC=NO
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.802; DZQLQEYLEYWJIB-UHFFFAOYSA-N; [M+H]+; 4-Aminobutyraldehyde
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.733; YNAVUWVOSKDBBP-UHFFFAOYSA-N; [M+H]+; Morpholine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.594; DNSISZSEWVHGLH-UHFFFAOYSA-N; [M+H]+; Butyramide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.542; PMDCZENCAXMSOU-UHFFFAOYSA-N; [M+H]+; N-Ethylacetamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.489; WFKAJVHLWXSISD-UHFFFAOYSA-N; [M+H]+; Isobutyramide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.489; FXHOOIRPVKKKFG-UHFFFAOYSA-N; [M+H]+; N,N-dimethylacetamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.489; SYJPAKDNFZLSMV-UHFFFAOYSA-N; [M+H]+; 2-methylpropanal oxime
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.400; VYONOYYDEFODAJ-UHFFFAOYSA-N; [M+H]+; 2-(1-Aziridinyl)ethanol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.385; KGGVGTQEGGOZRN-UHFFFAOYSA-N; [M+H]+; butanal oxime
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.333; WHIVNJATOVLWBW-SNAWJCMRSA-N; [M+H]+; butanone oxime
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.333; LUQZKEZPFQRRRK-UHFFFAOYSA-N; [M+H]+; 2-methyl-2-nitrosopropane
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.281; GRWPTSXPZYCYOM-UHFFFAOYSA-N; [M+H]+; 2-(dimethylamino)acetaldehyde
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.281; KVTGAKFJRLBHLU-UHFFFAOYSA-N; [M+H]+; N-isopropylformamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; DNSISZSEWVHGLH-UHFFFAOYSA-N; [M+H]+; Butyramide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; DZQLQEYLEYWJIB-UHFFFAOYSA-N; [M+H]+; 4-Aminobutyraldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; GRWPTSXPZYCYOM-UHFFFAOYSA-N; [M+H]+; 2-(dimethylamino)acetaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; PMDCZENCAXMSOU-UHFFFAOYSA-N; [M+H]+; N-Ethylacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; YNAVUWVOSKDBBP-UHFFFAOYSA-N; [M+H]+; Morpholine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; WFKAJVHLWXSISD-UHFFFAOYSA-N; [M+H]+; Isobutyramide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; FXHOOIRPVKKKFG-UHFFFAOYSA-N; [M+H]+; N,N-dimethylacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; KGGVGTQEGGOZRN-UHFFFAOYSA-N; [M+H]+; butanal oxime
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; SYJPAKDNFZLSMV-UHFFFAOYSA-N; [M+H]+; 2-methylpropanal oxime
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; VYONOYYDEFODAJ-UHFFFAOYSA-N; [M+H]+; 2-(1-Aziridinyl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; WHIVNJATOVLWBW-SNAWJCMRSA-N; [M+H]+; butanone oxime
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; KVTGAKFJRLBHLU-UHFFFAOYSA-N; [M+H]+; N-isopropylformamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; LUQZKEZPFQRRRK-UHFFFAOYSA-N; [M+H]+; 2-methyl-2-nitrosopropane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.000; LFQSCWFLJHTTHZ-UHFFFAOYSA-N; [M+ACN+H]+; ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.875; YNAVUWVOSKDBBP-UHFFFAOYSA-N; [M+H]+; morpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.976; FXHOOIRPVKKKFG-UHFFFAOYSA-N; [M+H]+; N,N-dimethylacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.344; DNSISZSEWVHGLH-UHFFFAOYSA-N; [M+H]+; butanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.145; WHIVNJATOVLWBW-UHFFFAOYSA-N; [M+H]+; N-butan-2-ylidenehydroxylamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.073; WFKAJVHLWXSISD-UHFFFAOYSA-N; [M+H]+; 2-methylpropanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.816; PMDCZENCAXMSOU-UHFFFAOYSA-N; [M+H]+; N-ethylacetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.748; LCGLNKUTAGEVQW-UHFFFAOYSA-N; [M+ACN+H]+; methoxymethane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.688; SYJPAKDNFZLSMV-HWKANZROSA-N; [M+H]+; (NE)-N-(2-methylpropylidene)hydroxylamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.554; VYONOYYDEFODAJ-UHFFFAOYSA-N; [M+H]+; 2-(aziridin-1-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.545; QJQAMHYHNCADNR-UHFFFAOYSA-N; [M+H]+; N-methylpropanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.543; JMIAPORGEDIDLT-UHFFFAOYSA-N; [M+H]+; ethyl ethanimidate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.523; KGGVGTQEGGOZRN-UHFFFAOYSA-N; [M+H]+; N-butylidenehydroxylamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.521; JHHZLHWJQPUNKB-UHFFFAOYSA-N; [M+H]+; pyrrolidin-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.421; DZQLQEYLEYWJIB-UHFFFAOYSA-N; [M+H]+; 4-aminobutanal
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.330; KVTGAKFJRLBHLU-UHFFFAOYSA-N; [M+H]+; N-propan-2-ylformamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.262; SUUDTPGCUKBECW-UHFFFAOYSA-N; [M+H]+; N-propylformamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.255; FNKSTXGVEUSZJJ-UHFFFAOYSA-N; [M+H]+; 3-methyl-1,3-oxazolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.214; FJLHLDBEZKTSOK-UHFFFAOYSA-N; [M+H]+; N-ethyl-N-methylformamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.169; LUQZKEZPFQRRRK-UHFFFAOYSA-N; [M+H]+; 2-methyl-2-nitrosopropane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.168; MIPHRQMEIYLZFZ-UHFFFAOYSA-N; [M+H]+; oxolan-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.161; OZQGLZFAWYKKLQ-UHFFFAOYSA-N; [M+H]+; oxazinane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.159; LQPOOAJESJYDLS-UHFFFAOYSA-N; [M+H]+; 1,3-oxazinane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.156; AVPAYFOQPGPSCC-UHFFFAOYSA-N; [M+H]+; 3-methoxyazetidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.140; LDLAEUFQUOXALI-UHFFFAOYSA-N; [M+H]+; 3-methylazetidin-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.135; OBMKZINZPBARIK-UHFFFAOYSA-N; [M+H]+; (1-aminocyclopropyl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.135; GNVWVYIAQBJHGV-UHFFFAOYSA-N; [M+H]+; azetidin-3-ylmethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.134; JLUZCHOYSPEHES-UHFFFAOYSA-N; [M+H]+; 3-aminocyclobutan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.133; NQVWMPOQWBDSAI-UHFFFAOYSA-N; [M+H]+; 3-methyloxetan-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.133; JXJORHGRCCODBV-UHFFFAOYSA-N; [M+H]+; 1-(aminomethyl)cyclopropan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.133; YHNRUSMOYCDMJS-UHFFFAOYSA-N; [M+H]+; O-(cyclopropylmethyl)hydroxylamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.133; UNCPWMREXAOVOD-UHFFFAOYSA-N; [M+H]+; 1-(methylamino)propan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.131; SUVYXKDAVYFUMG-UHFFFAOYSA-N; [M+H]+; 4-aminobutan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.131; KTHZBRAXOLUNBN-UHFFFAOYSA-N; [M+H]+; oxetan-3-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.131; IJVQAJHYYRVZNE-UHFFFAOYSA-N; [M+H]+; 1-methylazetidin-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.131; GOPUCFKUFOFEIC-UHFFFAOYSA-N; [M+H]+; 2-methyl-1,3-oxazolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.130; QCWWEZIJUCPALZ-UHFFFAOYSA-N; [M+H]+; 1-aminobutan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.129; OLYWGXUJESDUAC-UHFFFAOYSA-N; [M+H]+; 3-aminobutan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.129; FTWWNKCHSPDIQW-UHFFFAOYSA-N; [M+H]+; azetidin-2-ylmethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.129; QMOLZSLXSAVSPU-UHFFFAOYSA-N; [M+H]+; N-methoxypropan-2-imine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.128; JUIXJPRSYHSLHK-UHFFFAOYSA-N; [M+H]+; N-methyloxetan-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.127; QDEFNAHLCTUWAH-UHFFFAOYSA-N; [M+H]+; oxetan-2-ylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.127; WTUJMUAZXUEIEM-UHFFFAOYSA-N; [M+H]+; propan-2-yl methanimidate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.127; VEPSIZZAILVTSD-UHFFFAOYSA-N; [M+H]+; 1-aminobut-3-en-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.127; WXKBWWIWJCCING-IUYQGCFVSA-N; [M+H]+; (1R,2S)-2-aminocyclobutan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.126; WHFMUIWBJFYAGJ-UHFFFAOYSA-N; [M+H]+; O-cyclobutylhydroxylamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.126; YACWILRABGNJKG-IUYQGCFVSA-N; [M+H]+; [(1R,2R)-2-aminocyclopropyl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.126; RKBAYXYCMQLBCZ-SCSAIBSYSA-N; [M+H]+; (2R)-2-aminobut-3-en-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.125; QIFJASJJDSEUFV-UHFFFAOYSA-N; [M+H]+; 2-methylazetidin-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.125; CXBUEUVHLAPEIB-HWKANZROSA-N; [M+H]+; (E)-N-ethoxyethanimine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.125; VVBVTZZZFFHHSP-OWOJBTEDSA-N; [M+H]+; (E)-4-aminobut-2-en-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.125; BYJRDCYSJQJVJP-UHFFFAOYSA-N; [M+H]+; N-methoxyprop-2-en-1-amine
COMMENT: CONFIDENCE Level 4: Unequivocal precursor ion formula C4H10N1O1; Top hit by both SIRIUS6_Zodiac and MS-FINDER; and SevenGoldenRules(1);
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 Âµm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 2.379
MS$FOCUSED_ION: PRECURSOR_M/Z 88.075682
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-000i-9000000000-dba53a7ba9410a7e707d
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  56.0497349 15.9941 56.050447 1.0526 7.12 -0.6000 14 f{C3H6N1}/4.63ppm,p-C1H4O1
  58.0653418 12.1403 58.066062 0.8267 7.02 -0.4857 14 f{C3H8N1}/3.72ppm,p-C1H2O1
  59.0493892 7.0215 59.050113 0.8298 2.56 -0.6848 10 f{C3H7O1}/4.20ppm,p-C1H3N1
  68.9822762 8.2683 68.983019 0.9568 3.47 -0.0330 13 ?
  69.0336195 6.0255 69.034363 1.0719 1.92 0.2378 12 f{C4H5O1}/1.86ppm,p-H5N1
  70.0652567 39.8973 70.066000 0.4853 10.90 -0.2440 14 f{C4H8N1}/1.87ppm,p-H2O1
  71.0128547 14.2250 71.013598 0.7604 4.99 -0.0945 14 ?
  72.0445228 34.4694 72.045266 0.5136 10.67 0.3143 14 f{C3H6N1O1}/1.84ppm,p-C1H4
  72.9981748 10.5739 72.998917 0.7945 3.41 0.6176 14 ?
  86.0237010 5.4244 86.024408 1.7321 1.98 0.7212 10 ?
  86.0601025 16.3983 86.060809 1.1736 5.10 0.2835 14 f{C4H8N1O1}/0.72ppm,p-H2
  86.0964084 5.9056 86.097115 1.0221 2.25 -0.1888 12 ?
  86.9927941 7.5630 86.993496 1.1495 3.36 -0.6273 11 ?
  87.0441348 33.2742 87.044837 0.8846 9.61 0.2253 13 ?
  87.0553349 12.6901 87.056037 0.9994 3.09 -0.5330 13 ?
  87.0917225 999.0000 87.092424 0.3904 0.00 -0.2967 14 ?
  88.0215308 35.7175 88.022228 0.8066 14.87 0.3978 14 ?
  88.0393094 9.9010 88.040006 1.2154 2.86 -0.2440 14 ?
  88.0757253 57.5649 88.076422 0.6926 18.90 1.0000 14 f{C4H10N1O1}/0.40ppm,p
  88.0949640 43.8841 88.095661 1.0557 4.64 -0.3011 14 ?
  88.1120804 16.3470 88.112777 1.7364 22.90 0.3697 10 ?
PK$NUM_PEAK: 21
PK$PEAK: m/z int. rel.int.
  56.049735 15.99 15
  58.065342 12.14 12
  59.049389 7.02 7
  68.982276 8.27 8
  69.033620 6.03 6
  70.065257 39.90 39
  71.012855 14.22 14
  72.044523 34.47 34
  72.998175 10.57 10
  86.023701 5.42 5
  86.060103 16.40 16
  86.096408 5.91 5
  86.992794 7.56 7
  87.044135 33.27 33
  87.055335 12.69 12
  87.091722 999.00 999
  88.021531 35.72 35
  88.039309 9.90 9
  88.075725 57.56 57
  88.094964 43.88 43
  88.112080 16.35 16
//
